WHO ICTRP trial
The efficacy and safety of Amphotericin B Cholesterol Sulfate Complex for…
ChiCTR2500100402 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500100402 |
|---|---|
| Public title | The efficacy and safety of Amphotericin B Cholesterol Sulfate Complex for Injection versus Voriconazole in the empiric treatment of invasive fungal infections in critically ill patients:A multicentre RCT study |
| Scientific title | The efficacy and safety of Amphotericin B Cholesterol Sulfate Complex for Injection versus Voriconazole in the empiric treatment of invasive fungal infections in critically ill patients:A multicentre RCT study |
| Primary sponsor | The Affiliated Hospital of Medical College Qingdao University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Invasive Fungal Disease |
| Interventions | The control group:The control group received intravenous voriconazole as the antifungal treatment. The treatment course will be administered for a minimum of 14 days, with the decision to continue study medication beyond this period at the… |
| Registration date | Apr 9, 2025 |
| Target size | The control group:82;The experimental group:82 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: